Prime Medicine (PRME) Other Non-Current Assets (2021 - 2026)

Prime Medicine (PRME) has 6 years of Other Non-Current Assets data on file, last reported at $13.7 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets fell 2.64% year-over-year to $13.7 million; the trailing twelve-month figure through Mar 2026 stood at $13.7 million (down 2.64% YoY), and the FY2025 full-year result was $13.7 million, down 2.64% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $13.7 million, roughly flat from $13.7 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $14.1 million in Q3 2024 and bottomed at $779000.0 in Q4 2023.
• The 5-year median for Other Non-Current Assets is $13.5 million (2022), against an average of $12.2 million.
• The widest annual swing landed in 2022, when Other Non-Current Assets tumbled 87.44%; it then soared 1705.13% in 2024.
• A 5-year view of Other Non-Current Assets shows it stood at $1.6 million in 2022, then plunged by 52.67% to $779000.0 in 2023, then jumped by 1705.13% to $14.1 million in 2024, then retreated by 2.64% to $13.7 million in 2025, then changed by 0.0% to $13.7 million in 2026.
• The last three Other Non-Current Assets figures came in at $13.7 million (Q1 2026), $13.7 million (Q4 2025), and $13.7 million (Q3 2025), per Business Quant data.

Peer Comparison